During his time as CEO, John C. Jacobs held a significant number of stock options and shares in Harmony Biosciences. His most valuable assets were linked to the company's performance. In 2020, he had options covering over 187,000 shares exerciseable...

During his time as CEO, John C. Jacobs held a significant number of stock options and shares in Harmony Biosciences. His most valuable assets were linked to the company's performance. In 2020, he had options covering over 187,000 shares exerciseable at a price of $8.22, which he held as the stock price grew post-IPO. However, his stock options expired shortly after his resignation, reflecting a separation from the company he helped grow. As of his last year, his financial interests were deeply tied to the company's market performance, showcasing a typical executive's alignment with shareholder interests, although he did not hold vested stocks in his final year. Overall, his holdings indicate a financially savvy executive who capitalized on his role, though the exact present worth of his equity interests is unclear following his abrupt exit.